Proton pump inhibitor effect
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Proton pump inhibitor effect, abbreviated PPI effect, is a change seen in the parietal cells of the stomach due to a drug in the proton pump inhibitor class.
Formally, it is stomach with proton pump inhibitor effect.
General
- Due to intake of a proton pump inhibitor (PPI).
- Used to treat gastroesophageal reflux disease.
Some proton pump inhibitors
Generic name | Brand name(s) |
---|---|
Omeprazole | LOSEC |
Dexlansoprazole | DEXILANT |
Lansoprazole | PREVACID |
Esomeprazole | NEXIUM |
Pantoprazole | PANTOLOC |
Rabeprazole | PARIET |
Microscopic
- Parietal cell enlargement - key feature.
- Parietal cells typically bulge into the lumen.
- G cell and enterochromaffin cell-like hyperplasia.
- Compensatory change due to increased pH in gastric lumen.
- Multiple fundic gland polyps (with PPI use over several months).
- Polyps may regress after PPI is stopped.
Images
www:
Sign out
- Usually not reported.
See also
References
- ↑ Driman, DK.; Wright, C.; Tougas, G.; Riddell, RH. (Oct 1996). "Omeprazole produces parietal cell hypertrophy and hyperplasia in humans.". Dig Dis Sci 41 (10): 2039-47. PMID 8888719.
- ↑ topic/stomachPPI.html topic/stomachPPI